Influenza B virus causes annual epidemics and, along with influenza A virus, accounts for substantial disease and economic burden throughout the world. Influenza B virus infects only humans and some marine mammals and is not responsible for pandemics, possibly due to a very low frequency of reassortment and a lower evolutionary rate than that of influenza A virus. Influenza B virus has been less studied than influenza A virus, and thus, a
Influenza A and B viruses are important respiratory pathogens and cause seasonal epidemics with an estimated 250,000 to 500,000 deaths annually. Influenza A and B viruses are structurally similar: they are negative-sense RNA viruses with a singlestranded segmented genome. The genome is structured in eight viral ribonucleoprotein (vRNP) complexes where the singlestranded RNA (ssRNA) is associated with multiple nucleoprotein (NP) molecules and a polymerase complex consisting of the PB1, PB2, and PA proteins (1). The vRNP complexes are packaged in a matrix protein shell surrounded by a host-derived lipid envelope in which the viral glycoproteins hemagglutinin (HA) and neuraminidase (NA) are embedded. Influenza viruses bind to sialic acids on cell surface glycoproteins and enter the cells mainly via clathrin-mediated endocytosis but also by macropinocytosis and clathrin-independent entry pathways (2, 3). Influenza viruses take advantage of the host endocytic pathway; a reduction of pH during the maturation of endosomes induces a conformational change in viral HA molecules and triggers fusion between viral and endosomal membranes. Fusion is followed by the uncoating of the capsid by M1 dissociation due to acidification of the virion via the M2 ion channel protein. This results in the release of vRNPs into the cytosol. The influenza virus genome is then imported into the nucleus for transcription and replication of viral genes. Primary transcription of the viral genome is triggered by the virion-associated polymerase protein complex, which leads to the translation of early viral proteins in the cell cytoplasm. Newly synthesized polymerase, NP, and NS1 proteins are transported into the nucleus, where they initiate and regulate the replication and synthesis of cRNA and viral RNA (vRNA) molecules, followed by secondary rounds of transcription. At later stages of infection, new vRNP complexes are packaged in the nucleus, followed by M1-and nuclear export protein (NEP)-regulated export of vRNPs into the cytoplasm. Here they associate with viral envelope glycoproteins HA and NA on the plasma membrane, leading to budding of the newly formed viral particles (4).